As described above, all lcFAODs can be identified by specific acylcarnitine profiles in DBS [43, 55] (Table 1)
The mechanistic complementarity between GHRH-class compounds (which signal through the GHRH receptor) and GHRP-class compounds like ipamorelin (which signal through the ghrelin GHSR-1a receptor) is the rationale behind the CJC-1295 + Ipamorelin combined blend, where dual-receptor stimulation produces a different GH-release profile than either compound alone
Dean OM, Gray K, Dodd S, Villagonzalo KA, Brown E, Tonge B, Berk M, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] Gomez L.D., Noctor G., Knight M., Foyer C.H
Click here to learn more about Andrea and the [] Listen Mapping Post Traumatic Growth with Dushyanthi Satchi #375 Can there be growth within suffering